Department of Medicine 4 – Nephrology and Hypertension

Peculiarities in the panoramic radiograph of patients with secondary hyperparathyroidism due to terminal renal disease: a radiologic controlled comparative study (2022) Möst T, Jahn AE, Heller KM, Schiffer M, Adler W, Rohde M, Weber M, et al. Journal article High cholesterol absorption is associated with increased cardiovascular risk in haemodialysis patients: insights from the AURORA study (2022) Silbernagel G, Duarte K, Sadiku S, Fauler G, Maerz W, Schmieder R, Jardine AG, et al. Journal article Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy (2022) Aypek H, Krisp C, Lu S, Liu S, Kylies D, Kretz O, Wu G, et al. Journal article 10-YEAR CLINICAL EVENTS AVOIDED IN DIABETIC AND CHRONIC KIDNEY DISEASE HYPERTENSION PATIENTS TREATED WITH RADIOFREQUENCY RENAL DENERVATION: PROJECTIONS BASED ON 3-YEAR DATA FROM THE GLOBAL SYMPLICITY REGISTRY (2022) Schmieder R, Cao K, Esler M, Kandzari D, Lobo M, Sharp A, Mancia G, et al. Conference contribution EXPECTATION AND ACCEPTANCE OF A CLINICAL DECISION SUPPORT SOFTWARE BY NEPHROLOGIST END-USERS: THE CKDNAPP SURVEY (2022) Kotsis FK, Beachle H, Altenbuchinger M, Meiselbach H, Kosch R, Sabine S, Tanja B, Schultheiss UT Conference contribution GENERATION OF PATIENT-SPECIFIC HIPSC-PODOCYTES TO STUDY PHENOTYPE-SPECIFIC ALTERATIONS AND TEST THERAPEUTIC TARGETS EX VIVO (2022) Rose V, Sopel N, Ohs A, Warnecke C, Schiffer M, Müller-Deile J Conference contribution Different Murine Models of Kidney Injury Reveal a Common Pattern of Dysregulation within the Polyamine System in Favour of its Catabolic Pathways (2022) Sieckmann T, Ögel N, Kelterborn S, Boivin FJ, Schley G, Fähling M, Ashraf MI, et al. Journal article Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples: A Multicenter Diagnostic Phase III Trial (2022) Gwinner W, Karch A, Braesen JH, Khalifa AA, Metzger J, Naesens M, Van Loon E, et al. Journal article Reduction of Clinical Events in High-Risk Hypertension Patients Treated With Renal Denervation: A Modeled Estimate From 36-Month Global SYMPLICTY Registry Data (2022) Schlaich M, Pietzsch JB, Mahfoud F, Wiliams B, Mancia G, Narkiewicz K, Ruilope L, et al. Conference contribution Physician Preferences for Recommending Renal Denervation to Hypertensive Patients Is Influenced by Patients' Antihypertensive Medication Nonadherence Due to Medication Side Effects (2022) Wang TD, Schmieder R, Kandzari DE, Lee YH, Haro CF, Pathak A Conference contribution